Increase of the therapeutic effect on non-small‑cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro

Chen,Ying; Cao,Yong; Yang,Danlei; Li,Kaiyan; Wang,Zhengyun; Zhu,Jing; Bunjhoo,Hansvin; Xiong,Shengdao; Xu,Yongjian; Xiong,Weining

doi:10.3892/etm.2011.381

February 2012 Volume 3 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February 2012 Volume 3 Issue 2

Full Size Image

Article

Increase of the therapeutic effect on non-small‑cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro

Authors:
- Ying Chen
- Yong Cao
- Danlei Yang
- Kaiyan Li
- Zhengyun Wang
- Jing Zhu
- Hansvin Bunjhoo
- Shengdao Xiong
- Yongjian Xu
- Weining Xiong
View Affiliations / Copyright

Affiliations: Department of Respiratory Diseases, Tongji Hospital, Key Lab of Pulmonary Diseases of Health Ministry, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China
Pages: 255-260
|
Published online on: November 16, 2011

https://doi.org/10.3892/etm.2011.381
Expand metrics +

Abstract

Overexpression of Cyclin D1 and Bcl-xL proteins has often been found in non-small-cell lung cancer (NSCLC). These two genes may play a significant role in tumorigenesis. However, the combined inhibition of the two genes in vitro is unclear in NSCLC. In this study, the effect of a combined intervention on Cyclin D1 and Bcl-xL in NSCLC is assessed and discussed. Three recombinant plasmids that expressed a cytomegalovirus (CMV) promoter-driven micro30 short hairpin RNA (shRNA) targeting the Cyclin D1 gene (Cyclin D1 shRNA), the Bcl-xL gene (Bcl-xL shRNA) and a combination of the two genes (Cyclin D1-Bcl-xL shRNA), based on the plasmid pcDNA6.2‑GW/EmGFP-miR, were constructed. The cell lines A549 and NCI-H441 were divided into four groups; blank control (untreated cells), Cyclin D1 shRNA, Bcl-xL shRNA and Cyclin D1-Bcl-xL shRNA (transfected cells), respectively. The expression of mRNA and protein of Cyclin D1 or Bcl-xL was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting, respectively. The apoptosis and proliferation of the two cell lines were evaluated by dimethylthiazol-diphenyltetrazolium bromide (MTT), cell count and flow cytometry. The recombinant plasmid sufficiently mediated the RNA interference (RNAi) effects in A549 and NCI-H441 cells. The expression levels of mRNA and protein of Cyclin D1 or Bcl-xL in the three intervention groups were significantly reduced compared to the untreated cells (P<0.05). No statistical differences were found among the combined shRNAs and single shRNA regarding Cyclin D1 or Bcl-xL, respectively (P>0.05). In the assessment of proliferation and apoptosis, it was found that in all three intervention groups there was significant inhibition of cell proliferation and promotion of cell apoptosis compared with the untreated cells (P<0.05). Furthermore, the combined interference of the two genes was more effective than either single interference (P<0.05). Our results suggested that the combined targeting of Cyclin D1 and Bcl-xL genes has potential for NSCLC investigation, providing increased efficacy over Cyclin D1 or Bcl-xL inhibition alone.

View Figures

View References

1.	PC HoffmanAM MauerEE VokesLung cancerLancet355479485200010.1016/S0140-6736(00)82038-310841143
2.	SF AltekruseCL KosaryM KrapchoN NeymanR AminouW WaldronSEER cancer statistics review 1975–2007Available at: http://seer.cancer.Gov/csr/1975-2007.
3.	A JemalR SiegelE WardY HaoJ XuT MurrayMJ ThunCancer statisticsCA Cancer J Clin5871962008
4.	TE StinchcombeMA SocinskiCurrent treatments for advanced stage none small cell lung cancerProc Am Thorac Soc6233241200910.1513/pats.200809-110LC
5.	WR SmytheTreatment of stage I non-small cell lung carcinomaChest123181S187S200310.1378/chest.123.1_suppl.181S12527578
6.	V HirshSystemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approachCurr Oncol171323201010.3747/co.v17i2.54920404973
7.	AS LundbergRA WeinbergControl of the cell cycle and apoptosisEur J Cancer35531539199910.1016/S0959-8049(99)00292-010492624
8.	MF BuckleyKJ SweeneyJA HamiltonExpression and amplification of cyclin genes in human breast cancerOncogene82127213319938336939
9.	S RamalingamCP BelaniRecent advances in targeted therapy for non-small cell lung cancerExpert Opin Ther Targets1124557200710.1517/14728222.11.2.24517227238
10.	M StevensonTherapeutic potential of RNA interferenceN Engl J Med35117721777200410.1056/NEJMra04500415496626
11.	CJ SherrG1 phase progression: cycling on cueCell79551555199410.1016/0092-8674(94)90540-17954821
12.	V BaldinJ LukasMJ MarcoteM PaganoG DraettaCyclin D1 is a nuclear protein required for cell cycle progression in G1Genes Dev7812821199310.1101/gad.7.5.8128491378
13.	D ResnitzkyM GossenH BujardSI ReedAcceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible systemMol Cell Biol141669167919948114703
14.	EK HanSC NgN ArberM BegemannIB WeinsteinRoles of cyclinD1 and related genes in growth inhibition, senescence and apoptosisApoptosis4213219199910.1023/A:100961882414514634283
15.	C GillettV FantlR SmithAmplification and overexpression of cyclinD1 in breast cancer detected by immunohistochemical stainingCancer Res541812181719948137296
16.	W JiangSM KahnN TomitaAmplification and expression of the human cyclinD gene in esophageal cancerCancer Res522980298319921533816
17.	DC BetticherJ HeighwayPS HasletonPrognostic significance of CCND1 (cyclinD1) overexpression in primary resected non-small-cell lung cancerBr J Cancer73294300199610.1038/bjc.1996.528562333
18.	H HuangYD HuN LiY ZhuInhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNAOligonucleotides19151162200910.1089/oli.2008.017419355812
19.	DM BarnesCE GillettCyclin D1 in breast cancerBreast Cancer Res Treat52115199810.1023/A:1006103831990
20.	J BartkovaJ LukasH MüllerD LützhøftM StraussJ BartekCyclin D1 protein expression and function in human breast cancerInt J Cancer57353361199410.1002/ijc.29105703118168995
21.	S GansaugeF GansaugeM RamadaniH StobbeB RauN HaradaHG BegerOverexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosisCancer Res571634163719979134998
22.	DW StaceyCyclin D1 serves as a cell cycle regulatory switch in actively proliferating cellsCurr Opin Cell Biol15158163200310.1016/S0955-0674(03)00008-512648671
23.	XM YinSignal transduction mediated by Bid, apro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathwaysCell Res10161167200010.1038/sj.cr.729004511032168
24.	B Karczmarek-BorowskaA FilipJ WojcierowskiA SmolenE KorobowiczI Korszen-PileckaM ZdunekEstimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancerLung Cancer516169200610.1016/j.lungcan.2005.08.01016297499
25.	X LeiZ HuangM ZhongB ZhuS TangD LiaoBcl-xL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cellsActa Biochim Biophys Sin (Shanghai)39344350200710.1111/j.1745-7270.2007.00286.x17492131
26.	Y SasazawaY FutamuraE TashiroM ImotoVacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathwayCancer Sci100146014672009
27.	H Biliran JrY WangS BanerjeeH XuH HengA ThakurA BolligFH SarkarJD LiaoOverexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell lineClin Cancer Res1160756086200510.1158/1078-0432.CCR-04-241916115953
28.	X HuangT LinJ GuL ZhangJA RothLC StephensY YuJ LiuB FangCombined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograftGene Ther913791386200210.1038/sj.gt.330181012365003
29.	CA SledzBR WilliamsRNA interference and double stranded-RNA-activated pathwaysBiochem Soc Trans32952956200410.1042/BST032095215506933
30.	MJ BuenoI Pérez de CastroM MalumbresControl of cell proliferation pathways by microRNAsCell Cycle731433148200810.4161/cc.7.20.683318843198
31.	M JovanovicMO HengartnermiRNA and apoptosis: RNAs to die forOncogene2561766187200610.1038/sj.onc.120991217028597
32.	B DriscollL WuS BuckleyFL HallKD AndersonD WarburtonCyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growthAm J Physiol273L941L94919979374720
33.	ER SauterM HerlynSC LiuS LitwinJA RidgeProlonged response to antisense cyclin D1 in a human squamous cancer xenograft modelClin Cancer Res6654660200010690551
34.	EM BruckheimerBT GjertsenTJ McDonnellImplications of cell death regulation in the pathogenesis and treatment of prostate cancerSemin Oncol26382398199910482181
35.	IK KimYK JungDY NohYS SongCH ChoiBH OhES MasudaYK JungFunctional screening of genes suppressing TRAIL-induced apoptosis: distinctin hibitory activities of Bcl-XL and Bcl-2Br J Cancer88910917200310.1038/sj.bjc.660079512644829
36.	SH LeechRA OlieO GautschiInduction of apoptosis in lung cancer cells following bcl-xl antisense treatmentInt J Cancer86570576200010.1002/(SICI)1097-0215(20000515)86:4%3C570::AID-IJC20%3E3.0.CO;2-T10797273
37.	S WangD YangME LippmanTargeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonistsSemin Oncol30133142200310.1053/j.seminoncol.2003.08.01514613034
38.	X ZhangJ ZhangL WangH WeiZ TianTherapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft miceBMC Cancer7149200710.1186/1471-2407-7-14917683579
39.	P WeerasingheGE GarciaQ ZhuP YuanL FengL MaoN JingInhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotidesInt J Oncol31129136200717549413
40.	X ZhangJ ZhangH WeiZ TianSTAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genesOncol Rep1713771382200717487394

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Increase of the therapeutic effect on non-small‑cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles